164 related articles for article (PubMed ID: 11489758)
1. Alcoholism and risk for cancer of the cervix uteri, vagina, and vulva.
Weiderpass E; Ye W; Tamimi R; Trichopolous D; Nyren O; Vainio H; Adami HO
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):899-901. PubMed ID: 11489758
[TBL] [Abstract][Full Text] [Related]
2. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
[TBL] [Abstract][Full Text] [Related]
3. Correspondence re: Weiderpass et al., Alcoholism and risk of cancer of cervix uteri, vagina, and vulva. Cancer Epidemiol. Biomark. Prev., 10: 899-901, 2001.
Chiaffarino F; Gallus S; Negri E; Parazzini F; Franceschi S; La Vecchia C
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):325-6. PubMed ID: 11895888
[No Abstract] [Full Text] [Related]
4. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
[TBL] [Abstract][Full Text] [Related]
5. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 13 cases with vaginal intraepithelial neoplasia].
Yang Y; Gao YL; Yu AJ; Zhang JJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Mar; 45(3):197-200. PubMed ID: 20450756
[TBL] [Abstract][Full Text] [Related]
8. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
10. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
11. Sex and genital cancer in heterosexual women.
Singer A
J Reprod Med; 1983 Feb; 28(2):109-15. PubMed ID: 6300392
[No Abstract] [Full Text] [Related]
12. [Incidence of precancerous states an carcinomas of the vulva in young women].
Basta A; Adamek K; Pawlak M; Przeszlakowski D
Przegl Lek; 1999; 56(1):20-2. PubMed ID: 10375919
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
14. Bleeding symptoms and subsequent risk of gynecological and other cancers.
Viikki M; Pukkala E; Hakama M
Acta Obstet Gynecol Scand; 1998 May; 77(5):564-9. PubMed ID: 9654181
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cancer among patients with atopic dermatitis.
Hagströmer L; Ye W; Nyrén O; Emtestam L
Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309
[TBL] [Abstract][Full Text] [Related]
16. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
17. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia.
Goodman MT; McDuffie K; Hernandez B; Wilkens LR; Bertram CC; Killeen J; Le Marchand L; Selhub J; Murphy S; Donlon TA
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1275-80. PubMed ID: 11751445
[TBL] [Abstract][Full Text] [Related]
18. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development.
Gunnell AS; Tran TN; Torrång A; Dickman PW; Sparén P; Palmgren J; Ylitalo N
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2141-7. PubMed ID: 17057029
[TBL] [Abstract][Full Text] [Related]
19. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
